IRIS
CANTARINI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.366
EU - Europa 18.453
AS - Asia 2.527
OC - Oceania 33
SA - Sud America 30
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 16
Totale 41.446
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.326
GB - Regno Unito 6.975
IE - Irlanda 2.976
IT - Italia 2.416
CN - Cina 1.736
UA - Ucraina 1.609
SE - Svezia 1.361
FR - Francia 871
DE - Germania 824
RU - Federazione Russa 551
FI - Finlandia 527
SG - Singapore 308
VN - Vietnam 162
TR - Turchia 75
IN - India 63
CZ - Repubblica Ceca 62
ES - Italia 55
JP - Giappone 51
PL - Polonia 51
BE - Belgio 50
NL - Olanda 37
CA - Canada 30
AU - Australia 28
IR - Iran 26
PK - Pakistan 25
HK - Hong Kong 20
CH - Svizzera 17
EU - Europa 16
BR - Brasile 12
CL - Cile 8
GR - Grecia 8
ID - Indonesia 7
MA - Marocco 7
MK - Macedonia 7
PT - Portogallo 7
RO - Romania 7
BG - Bulgaria 6
DK - Danimarca 6
EE - Estonia 6
KR - Corea 6
EG - Egitto 5
NZ - Nuova Zelanda 5
PH - Filippine 5
BD - Bangladesh 4
CY - Cipro 4
HU - Ungheria 4
MY - Malesia 4
PA - Panama 4
AL - Albania 3
AR - Argentina 3
AT - Austria 3
DZ - Algeria 3
IL - Israele 3
LT - Lituania 3
LV - Lettonia 3
MX - Messico 3
PE - Perù 3
RS - Serbia 3
SA - Arabia Saudita 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BO - Bolivia 2
CR - Costa Rica 2
ET - Etiopia 2
IQ - Iraq 2
KE - Kenya 2
KZ - Kazakistan 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UZ - Uzbekistan 2
AM - Armenia 1
BY - Bielorussia 1
CO - Colombia 1
EC - Ecuador 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MM - Myanmar 1
NG - Nigeria 1
TM - Turkmenistan 1
ZA - Sudafrica 1
Totale 41.446
Salva come PNG Salva come JPEG
Città #
Southend 6.689
Fairfield 3.331
Dublin 2.933
Ashburn 1.733
Chandler 1.705
Woodbridge 1.578
Wilmington 1.347
Jacksonville 1.313
Houston 1.301
Seattle 1.250
Cambridge 1.124
Ann Arbor 840
Siena 705
Menlo Park 653
Princeton 534
Nanjing 450
Beijing 335
Helsinki 282
Boardman 251
New York 244
San Mateo 232
San Diego 197
Singapore 192
Dong Ket 161
Nanchang 141
Moscow 138
Milan 133
Düsseldorf 127
Florence 120
Shenyang 118
Dearborn 99
Rome 96
Shanghai 76
Tianjin 70
Hebei 68
Jiaxing 66
London 66
Washington 66
Changsha 61
Izmir 53
Jinan 51
Venezia 51
Kunming 50
Norwalk 49
Málaga 47
Brussels 44
Kraków 38
Olomouc 36
Fremont 34
Guangzhou 34
Redwood City 34
Frankfurt am Main 31
San Francisco 30
Zhengzhou 30
Los Angeles 29
Chicago 27
Munich 27
Bologna 25
Lancaster 25
Brno 23
Hangzhou 23
Dallas 22
Tappahannock 22
Taizhou 21
Falls Church 20
Toronto 20
Changchun 19
Lanzhou 19
Naples 19
Ningbo 19
Padova 19
Livorno 18
Catania 17
Paris 15
Turin 14
Perugia 13
Saint Petersburg 13
Cecina 12
Hounslow 12
Aachen 11
Bari 11
Chianciano Terme 11
Palermo 11
Renton 11
Uzzano 11
Verona 11
Amsterdam 10
Asciano 10
Comun Nuovo 10
Hyderabad 10
Lappeenranta 10
Zanjan 10
Bergamo 9
Carrara 9
Hefei 9
Monza 9
Salerno 9
Sutri 9
Edinburgh 8
Lahore 8
Totale 32.137
Salva come PNG Salva come JPEG
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 367
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis 261
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 250
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 241
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 227
Antiangiogenic VEGF isoform in inflammatory myopathies 215
The 2014 ACR annual meeting: a bird's eye view of autoimmunity in 2015 215
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 206
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 203
Eosinophilia-associated muscle disorders:an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms 200
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 195
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 194
Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups 192
Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review 191
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 191
Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS) 191
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 189
Weekly oral alendronate in mevalonate kinase deficiency 188
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 186
Macrophage activation syndrome in the course of monogenic autoinflammatory disorders 186
Antirheumatic agents in covid-19: is IL-6 the right target? 184
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 183
Peripheral biomarkers' panel for severe COVID-19 patients 182
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 181
Eosinophils in inflammatory muscle disorders: a morphologic and immunohistological study. 180
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 178
Colchicine myopathy and neuromyopathy: two cases with different characteristics 178
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 177
Genetic mechanisms of critical illness in COVID-19 177
SAT0564 Articular Involvement in Behçet Disease: An Ultrasonographic Study 175
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 172
Partial Rescue of Biochemical Parameters After Hematopoietic Stem Cell Transplantation in a Patient with Prolidase Deficiency Due to Two Novel PEPD Mutations 171
null 171
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 169
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 169
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders 168
Typical and severe tumor necrosis factor receptor-associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series 168
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 167
Working the endless puzzle of hereditary autoinflammatory disorders. 166
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 166
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis 164
Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: a multicenter retrospective observational study 161
Recommendations for the management of autoinflammatory diseases 160
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature 160
Untangling the Web of Systemic Autoinflammatory Diseases 159
Kawasaki syndrome and concurrent Coxsackie virus B3 infection 158
Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease 157
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 155
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria 155
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 154
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 154
Autoinflammatory disorders and patients with isolated serosal involvement. 153
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 153
Short- and long-term effects of spa therapy in knee osteoarthritis 151
null 150
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 150
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). 149
Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry 149
IL-6 blockade in the management of non-infectious uveitis 149
Mechanisms of action of spa therapies in rheumatic diseases: what scientific evidence is there? 148
Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis 148
Systemic-onset juvenile idiopathic arthritis complicated by early onset amyloidosis in a patient carrying a mutation in the MEFV gene 147
Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings 147
Immunometabolic biomarkers of inflammation in Behçet's disease: Relationship with epidemiological profile, disease activity and therapeutic regimes 146
Glucocorticoids in the management of systemic juvenile idiopathic arthritis 146
The hereditary autoinflammatory disorders uncovered 145
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 145
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 145
Therapeutic effect of spa therapy and short wave therapy in knee osteoarthritis: a randomized, single blind, controlled trial 144
Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease 143
Use of Interleukin-1 Blockers in Pericardial and Cardiovascular Diseases 143
Safety and efficacy of etanercept in children with juvenile-onset Behcets disease 142
The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases 142
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 141
Tumour necrosis factor receptor-associated periodic syndrome(TRAPS): State of the art and future perspectives 140
Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature 140
Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease 139
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature 139
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study 139
The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry 138
Coexistence of axial spondyloarthritis and thromboangiitis obliterans in a young woman 138
Efficacy of cyclosporine A treatment in relapsing febrile lobular panniculitis associated with small vessel vasculitis 137
null 136
Clinical and biochemical landmarks in systemic autoinflammatory diseases 136
The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study 136
null 136
Efficacy of alendronate in the treatment of the SAPHO syndrome. 136
Biological treatments in Behçet's disease: beyond anti-TNF therapy 135
Monogenic autoinflammatory syndromes at a dermatological level 135
null 135
Effects of Spa therapy on serum leptin and adiponectin levels in patients with knee osteoarthritis 134
Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes 134
Possible chondroprotective effect of canakinumab: an in vitro study on human osteoarthritic chondrocytes 134
Tocilizumab-induced exacerbation of mucosal ulcers in a patient with multi-refractory Behçet's disease 134
Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism 134
Effect of hyaluronic acid (MW 500-730 kDa) on proteoglycan and nitric oxide production in human osteoarthritic chondrocyte cultures exposed to hydrostatic pressure 134
What do cytokine profiles tell us about subsets of juvenile idiopathic arthritis? 133
The protean ocular involvement in monogenic autoinflammatory diseases: state of the art 133
null 133
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives 133
Totale 16.414
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.246
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.547 0 361 570 1.257 458 779 697 1.022 830 776 283 514
2020/20216.819 411 746 218 681 428 992 276 985 409 587 454 632
2021/20225.064 494 562 335 331 285 183 226 204 365 626 504 949
2022/20236.256 407 417 728 886 617 1.260 238 505 663 138 242 155
2023/20245.345 238 163 487 283 233 1.348 1.559 210 43 164 167 450
2024/20251.073 586 487 0 0 0 0 0 0 0 0 0 0
Totale 42.672